Sun Pharmaceutical Industries’ US-based arm -- Sun Pharmaceutical Inc is recalling 16,450 vials of Norepinephrine Bitartrate Injection for ‘Failed Impurities/Degradation Specifications’. The company is recalling a generic drug indicated to raise blood pressure in adult patients with acute hypotension. The affected lot has been manufactured by Hyderabad-based Gland Pharma and distributed in the US by Sun Pharmaceutical Industries. Sun Pharmaceutical Inc initiated the Class III nationwide recall (US) on March 29 this year.
Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.
